Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccent Cap 49 Regulatory News (93FO)

Share Price Information for Accent Cap 49 (93FO)

Share Price is delayed by 15 minutes
Get Live Data
55.2202    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
93FO Live PriceLast checked at - London Stock Exchange

Intraday Accent Cap 49 Share Chart

Group Reorganisation

2 Apr 2024 07:00

RNS Number : 6108H
Accent Capital PLC
02 April 2024
 

Accent Capital PLC2 April 2024

Accent Group Limited1

Group Reorganisation

 

Accent Housing Limited (a subsidiary of Accent Group Limited) has on 31 March 2024 accepted a transfer of engagements from its subsidiary Domus Services Limited (registration number 9204), pursuant to section 110 of the Co-operative and Community Benefit Societies Act 2014.

The completion of this group reorganisation simplifies the group structure.

 -ENDS-

Issued by Accent Housing, Shipley, West Yorkshire. For more information, contact Stacey Healey, Head of Communications and Public Affairs on 03003739694 or email press.office@accentgroup.org.

Editor's Notes

1 Accent Group Limited is the ultimate holding company for Accent Capital PLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREAEDEADLLEFA
Date   Source Headline
12th Feb 20261:59 pmRNS-RExecutive Team Announcements
2nd Feb 20267:00 amRNSDirectorate change
9th Dec 202510:00 amRNSHalf-year Financial Report - Unaudited
3rd Nov 20253:00 pmRNS-RAccent announces Executive Team appointments
30th Sep 20255:00 pmRNS-RAccent Group publishes ESG Report
25th Sep 20253:08 pmRNSDirectorate Change
1st Aug 20259:30 amRNSCompany Secretary Change
1st Aug 20259:20 amRNSDirectorate Change
31st Jul 202512:30 pmRNSAnnual Financial Report
22nd Jul 20251:13 pmRNS-RAccent Group credit rating affirmation
11th Apr 20251:30 pmRNSDirectorate Change
6th Mar 20253:15 pmRNSInvestor Update
6th Mar 20252:49 pmRNS-RAccent Investor Update
12th Feb 20253:48 pmRNSAccent Announces New Board Members
9th Aug 20242:00 pmRNSAnnual Financial Statements 2023/24
5th Aug 202411:00 amRNSDirectorate Change
14th Jun 20247:00 amRNSAccent Announces New Executive Team Member
2nd Apr 20247:00 amRNSGroup Reorganisation
27th Mar 20241:00 pmRNSChange of Registered Office
20th Feb 202410:00 amRNSInterim CEO Announcement
18th Jan 202411:00 amRNSDirectorate Change
16th Nov 20234:00 pmRNSInvestor Update
14th Aug 20233:41 pmRNSSenior Independent Director Appointment
8th Aug 20235:00 pmRNSAnnual Financial Report
20th Jul 20234:08 pmRNSRatings Update
31st Mar 20235:11 pmRNSAppointment of Non Executive Independent Members
31st Mar 202312:08 pmRNSCompany Secretary Change
10th Mar 202312:00 pmRNSDirectorate Change
17th Jan 20237:00 amRNSBoard Member Retirement
13th Dec 202210:00 amRNSChange of Auditors
17th Nov 202210:30 amRNSInvestor Update
30th Aug 20223:00 pmRNSAnnual Financial Report
18th Jul 20223:56 pmRNSRatings Update
18th Feb 202212:44 pmRNSNew Board Members Appointed
9th Nov 202111:00 amRNSDirectorate Change
6th Oct 202111:00 amRNSIssue of Debt
14th Jul 20217:00 amRNSAnnual Financial Report
15th Jun 20219:00 amRNSDirectorate Change
21st May 20219:00 amRNSStatement re Partnership Discussions
23rd Mar 202110:00 amRNSPartnership Discussions
23rd Mar 202110:00 amRNSPartnership Discussions
14th Jul 20207:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.